Aier Eye Hospital Group Future Growth

Future criteria checks 5/6

Aier Eye Hospital Group wird ein jährliches Wachstum der Erträge und Einnahmen um 23.8% bzw. 21.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich grow um 23.3% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 21.1% betragen.

Key information

23.0%

Earnings growth rate

22.5%

EPS growth rate

Healthcare earnings growth	28.0%
Revenue growth rate	21.4%
Future return on equity	20.8%
Analyst coverage	Good
Last updated	22 Mar 2024

Recent future growth updates

Recent updates

Calculating The Intrinsic Value Of Aier Eye Hospital Group Co., Ltd. (SZSE:300015)

Apr 02

Many Would Be Envious Of Aier Eye Hospital Group's (SZSE:300015) Excellent Returns On Capital

Mar 15

Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Shares May Have Run Too Fast Too Soon

Feb 29

Earnings and Revenue Growth Forecasts

SZSE:300015 - Analysts future estimates and past financials data (CNY Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	30,807	5,523	5,645	7,435	18
12/31/2024	25,431	4,404	4,462	6,131	19
12/31/2023	20,607	3,509	4,050	5,099	19
9/30/2023	19,106	3,348	4,446	6,063	N/A
6/30/2023	18,254	2,945	4,139	5,544	N/A
3/31/2023	16,962	2,695	3,764	5,110	N/A
12/31/2022	16,110	2,524	3,102	4,491	N/A
9/30/2022	16,456	2,677	3,426	4,840	N/A
6/30/2022	15,760	2,499	3,067	4,488	N/A
3/31/2022	15,658	2,450	2,869	4,376	N/A
1/1/2022	15,001	2,323	2,590	4,084	N/A
9/30/2021	14,943	2,181	2,666	4,037	N/A
6/30/2021	15,096	2,163	3,263	4,586	N/A
3/31/2021	13,782	2,128	3,017	4,095	N/A
12/31/2020	11,912	1,724	2,450	3,344	N/A
9/30/2020	10,824	1,694	2,122	2,778	N/A
6/30/2020	9,405	1,360	1,112	1,751	N/A
3/31/2020	9,387	1,160	983	1,637	N/A
12/31/2019	9,990	1,379	1,333	2,078	N/A
9/30/2019	9,616	1,345	1,218	2,022	N/A
6/30/2019	8,978	1,195	903	1,619	N/A
3/31/2019	8,506	1,091	692	1,536	N/A
12/31/2018	8,009	1,009	589	1,400	N/A
9/30/2018	7,705	1,005	825	1,802	N/A
6/30/2018	7,153	890	751	1,690	N/A
3/31/2018	6,512	803	755	1,466	N/A
12/31/2017	5,963	743	725	1,330	N/A
9/30/2017	5,300	721	587	992	N/A
6/30/2017	4,671	646	N/A	873	N/A
3/31/2017	4,283	594	N/A	798	N/A
12/31/2016	4,000	557	N/A	775	N/A
9/30/2016	3,807	538	N/A	624	N/A
6/30/2016	3,631	499	N/A	630	N/A
3/31/2016	3,429	459	N/A	537	N/A
12/31/2015	3,166	428	N/A	522	N/A
9/30/2015	3,006	413	N/A	479	N/A
6/30/2015	2,740	367	N/A	480	N/A
3/31/2015	2,535	331	N/A	484	N/A
12/31/2014	2,402	309	N/A	454	N/A
9/30/2014	2,316	296	N/A	486	N/A
6/30/2014	2,200	266	N/A	428	N/A
3/31/2014	2,091	240	N/A	438	N/A
12/31/2013	1,985	223	N/A	413	N/A
9/30/2013	1,928	217	N/A	421	N/A
6/30/2013	1,799	193	N/A	363	N/A

Analyst Future Growth Forecasts

Einkommen vs. Sparrate: 300015Das prognostizierte Gewinnwachstum (23.8% pro Jahr) liegt über der Sparquote (2.9%).

Ertrag vs. Markt: 300015Die Erträge des Unternehmens (23.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt CN (25.3% pro Jahr).

Hohe Wachstumserträge: 300015Es wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: 300015Die Einnahmen des Unternehmens (21.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt CN (13.9% pro Jahr).

Hohe Wachstumseinnahmen: 300015Die Einnahmen des Unternehmens (21.9% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.

Earnings per Share Growth Forecasts

Future Return on Equity

Künftige Eigenkapitalrendite: 300015Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (21.1%)

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Aier Eye Hospital Group Future Growth

Future criteria checks 5/6

Key information

Recent future growth updates

Price target decreased by 8.5% to CN¥24.37

Price target decreased by 8.2% to CN¥27.91

Consensus forecasts updated

Price target decreased to CN¥59.67

Price target increased to CN¥92.13

Price target raised to CN¥80.59

Recent updates

Calculating The Intrinsic Value Of Aier Eye Hospital Group Co., Ltd. (SZSE:300015)

Aier Eye Hospital Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Many Would Be Envious Of Aier Eye Hospital Group's (SZSE:300015) Excellent Returns On Capital

Aier Eye Hospital Group Co., Ltd.'s (SZSE:300015) Shares May Have Run Too Fast Too Soon

Aier Eye Hospital Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Price target decreased by 8.5% to CN¥24.37

Aier Eye Hospital Group Co., Ltd. (SZSE:300015) announces an Equity Buyback for CNY 300 million worth of its shares.

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 8.2% to CN¥27.91

Second quarter 2023 earnings: EPS misses analyst expectations

Aier Eye Hospital Group Co., Ltd. to Report First Half, 2023 Results on Aug 25, 2023

Less than half of directors are independent

Aier Eye Hospital Group Co., Ltd. Announces Cash Dividend, Payable 08 June 2023

Aier Eye Hospital Group Co., Ltd. (SZSE:300015) announces an Equity Buyback for CNY 500 million worth of its shares.

Full year 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.33 in FY 2021)

Aier Eye Hospital Group Co., Ltd. Announces Board Appointments

Less than half of directors are independent

Consensus forecasts updated

Now 24% undervalued after recent price drop

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Second quarter 2022 earnings: EPS exceeds analyst expectations

Now 21% undervalued

Aier Eye Hospital Group Co., Ltd. Announces Cash Dividend for A Shares for the Year 2021, Payable on 11 July 2022

Aier Eye Hospital Group Co., Ltd. Approves Cash Dividend for 2021

Now 22% undervalued

Now 28% undervalued after recent price drop

Aier Eye Hospital Group Co., Ltd. Announces Profit Distribution Proposal for 2021

First quarter 2022 earnings: EPS misses analyst expectations

Less than half of directors are independent

Now 21% undervalued after recent price drop

Price target decreased to CN¥59.67

Investor sentiment deteriorated over the past week

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.16 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.11 in 2Q 2020)

Aier Eye Hospital Group Co., Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.02 in 1Q 2020)

Price target increased to CN¥92.13

Aier Eye Hospital Group Co., Ltd. to Report Fiscal Year 2020 Results on Apr 23, 2021

New 90-day low: CN¥63.79

Price target raised to CN¥80.59

New 90-day high: CN¥85.99

New 90-day high: CN¥80.70

New 90-day high: CN¥77.40

New 90-day high: CN¥69.81

Price target raised to CN¥68.78

New 90-day high: CN¥69.71

Price target raised to CN¥61.31

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings beat expectations

New 90-day high: CN¥61.46

Aier Eye Hospital Group Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high: CN¥57.20

Price target raised to CN¥53.20

New 90-day high - CN¥49.98

Earnings released

Aier Eye Hospital Group Co., Ltd. to Report First Half, 2020 Results on Aug 26, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies